Worldwide, infectious diseases not only affect the health of millions annually but also incur an immeasurable economic cost. The transmission of pathogenic viruses in public areas has been a long-standing issue. Stainless steel (SS) is one of the most extensively used materials in public areas and hygiene facilities, such as door handles, elevator buttons, handrails, countertops, etc. However, SS lacks inherent properties to combat pathogen microbes on its surfaces, posting a high risk of disease transmission among people via surface touching. Additionally, certain pathogens, like SARS-CoV-2, exhibit strong stability on SS surfaces, with viable viruses detected even after three days.
To address this challenge, the technology owner has developed anti-pathogen stainless steel, which is a significant breakthrough in the field of anti-microbial SS. It stands as the world’s first SS capable of combating the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) on its surface. Furthermore, its antimicrobial properties are broad-spectrum and can inactivate many other pathogen microbes, such as the H1N1 influenza A virus (H1N1) and Escherichia coli (E. coli).
Unlike surface coatings that may wear off over time, the antimicrobial precipitates are permanently embedded in the whole SS matrix, providing long-term inherent antimicrobial properties. Thus, this anti-pathogen SS can effectively and chronically inactivate pathogen microbes even though its surface is continuously damaged.
The technology owner is keen to do R&D collaboration and licensing to application developers intending to implement anti-pathogen SS in various industries.
This anti-pathogen stainless steel has the following technical features:
The anti-pathogen and anti-COVID-19 SS can be customised for various products and applications, particularly those with high hygiene requirements. The potential applications include but are not limited to:
The breakthrough technology offers the following unique features:
The technology owner is keen to do R&D collaboration and licensing to application developers intending to implement anti-pathogen SS in various industries.